Eugene D. Kwon

20.8k citations
181 papers · 16.7k · 6 hit papers · h-index 63

Impact in

  • Oncology top 0.2%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
  • Immunology top 0.2%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • Prostate Cancer Treatment and Research 38
    • Prostate Cancer Diagnosis and Treatment 35
    • Renal cell carcinoma treatment 35
    • Cancer Immunotherapy and Biomarkers 37
    • CAR-T cell therapy research 15

Eugene D. Kwon

178 papers receiving 16.3k citations

Eugene D. Kwon's Hit Papers

Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer 2016 · 619 citations
6190+7+15Years since publication4008001.2k

Peers

Eugene D. Kwon
Comparison fields: 5 of 150
  • Oncology 7.0k
  • Immunology 5.1k
  • Pulmonary and Respiratory Medicine 6.5k
  • Cancer Research 1.5k
  • Molecular Biology 3.0k
Replace Ajjai Shivaram Alva with:
Ajjai Shivaram Alva United States
Genichiro Ishii Japan
C. Blake Gilks Canada
Marc‐Oliver Grimm Germany
Raanan Berger Israel
Massimo G. Roncalli Italy
Hans‐Georg Kopp Germany
Tanguy Y. Seiwert United States
Silvana Pilotti Italy
Eugene D. Kwon relative to Ajjai Shivaram Alva United States Ajjai Shivaram Alva's profile →
Citations per field
00.5×2×4×5.4×
Ajjai Shivaram Alva · 1×
Citations per year

Countries citing papers authored by Eugene D. Kwon

Since Specialization
Citations

This map shows the geographic impact of Eugene D. Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene D. Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene D. Kwon more than expected).

Fields of papers citing papers by Eugene D. Kwon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene D. Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene D. Kwon. The network helps show where Eugene D. Kwon may publish in the future.

Co-authors

The 25 scholars most cited alongside Eugene D. Kwon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eugene D. Kwon Line = papers co-authored together Eugene D. Kwon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 181 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Hit paper breakdown →
20141259
2
Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up
Hit paper breakdown →
2006752
3 2004690
4
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma
Hit paper breakdown →
2003646
5
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
Hit paper breakdown →
2016619
6
Clinical significance of defective dendritic cell differentiation in cancer.
2000607
7
Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy
Hit paper breakdown →
2008556
8
PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma
Hit paper breakdown →
2007482
9 2007387
10
Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade.
2000375
11 1997350
12 1997343
13 2001342
14 2015331
15 2011306
16 2006256
17 2008240
18 2008236
19 2004233
20 2006232

About Eugene D. Kwon

Eugene D. Kwon is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Surgery and Rheumatology, having authored 181 papers that have together received 16.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (38 papers), Cancer Immunotherapy and Biomarkers (37 papers), Prostate Cancer Diagnosis and Treatment (35 papers), Renal cell carcinoma treatment (35 papers), Immunotherapy and Immune Responses (34 papers), CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (11 papers) and Renal and related cancers (9 papers). The work is most often cited by research in Oncology (7.0k citations), Immunology (5.1k citations), Pulmonary and Respiratory Medicine (6.5k citations), Cancer Research (1.5k citations) and Molecular Biology (3.0k citations). Eugene D. Kwon has collaborated with scholars based in United States, Italy and Slovakia. Frequent co-authors include Bradley C. Leibovich, Christine Marie Lohse, Michael L. Blute, John C. Cheville, Robert Houston Thompson, Haidong dong, Horst Zincke, Igor Frank, Maurice B. Burg and Susan M. Kuntz. Their work appears in journals such as The Journal of Urology, Cancer, Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact